Medizinische Universität Graz - Research portal
Moser Tina |
Presentations at scientific and public conferences
Moser, T
ML-gestütztes multi-modales Liquid Profiling.
27. IGLD - INSTAND Jahressymposium; MAR 6-8, 2025; Frankfurt, GERMANY. 2025.
[Oral Communication]
Bonstingl, L; Zinnegger, M; Sallinger, K; Skofler, C; Ulz, C; Pritz, E; Pankratz, K; Odar, C; Gruber, MC; Borrás-Cherrier, A; Somodi, V; Abuja, PM; Oberauner-Wappis, L; Kühberger, S; Moser, T; Heitzer, E; Bauernhofer, T; Kroneis, T; El-Heliebi, A;
A Liquid biopsy multi-analyte approach deciphering treatment resistance in prostate cancer supported by machine learning
EACR Liquid Biopsy; NOV 12-14, 2024; Lyon, FRANCE. 2024.
[Poster]
Bonstingl, L; Zinnegger, M; Sallinger, K; Skofler, C; Ulz, C; Pritz, E; Pankratz, K; Odar, C; Gruber, MC; Borrás-Cherrier, A; Somodi, V; Abuja, PM; Oberauner-Wappis, L; Moser, T; Heitzer, E; Bauernhofer, T; Kroneis, T; El-Heliebi, A;
Longitudinal tracking of drug resistance in metastatic prostate cancer
Circulating Nucleic Acids in Plasma and Serum (CNAPS); MAR 4-6, 2024; Graz, AUSTRIA. 2024.
[Poster]
Moser, MJ; Moser, T; Heitzer E
Mathematical approaches boost circulating tumor DNA detection via fragmentomics.
EACR - Liquid Biopsies; NOV 12-14, 2024; Lyon, FRANCE. 2024.
[Poster]
Moser, T
Neue diagnostische Methoden – Potential und Beschränkungen.
Interdisziplinäre T.U.M.O.R. Tage; MAR 15-17, 2024; Salzburg, AUSTRIA. 2024.
[Oral Communication]
Moser, T
Multimodale ctDNA-Diagnostik.
Deutscher Kongress für Laboratoriumsmedizin
; SEP 26-27, 2024; Bremen, GERMANY. 2024.
[Oral Communication]
Moser, T
It’s in our blood: liquid biopsy to detect, treat, and track cancer.
Cancer Research Day; OCT 16, 2024; Graz, AUSTRIA. 2024.
[Oral Communication]
Moser, T; Eberhard, A; Moser, MJ; Glawitsch, L; Hammer, S; Vlachos, G; Lazzeri, I; Ziegler, L; Bauernhofer, E; Monsberger N; Geigl, JB; Bauernhofer, T; Heitzer, E
Linking liquids: cfDNA in urine and plasma as informative allies in metastasized prostate cancer.
Annual Meeting 2024. 2024; -AACR; APR 5-10, 2024; San Diego, USA.
[Poster]
FullText
Moser, T; Moser, MJ; Eberhard, A; Ziegler, L; Bauernhofer, T; Heitzer E
Fragmentomics in focus: how urine collection shapes liquid biopsy analysis.
EACR - Liquid Biopsies; NOV 12-14, 2024; Lyon, FRANCE. 2024.
[Poster]
Moser, T; Vlachos, G; Heitzer, E
Whole exome sequencing of cfDNA in metastatic prostate cancer.
Circulating Nucleic Acids in Plasma and Serum (CNAPS); MAR 4-6, 2024; Graz, AUSTRIA. 2024.
[Oral Communication]
FullText
Vlachos, G; Moser, T; Eberhard, A ; Bauernhofer, T; Heitzer, E
ctDNA can infer Homologous Recombination Deficiency in mCRPC patients.
.
Circulating Nucleic Acids in Plasma and Serum (CNAPS); MAR 4-6, 2024; Graz, AUSTRIA. 2024.
[Poster]
Vlachos, G; Moser, T; Eberhard, A; Bauernhofer, T; Heitzer, E
CTDNA-based detection of homologous recombination deficiency in MCRPC patients.
ISLB. 2024; -International Society of Liquid Biopsy; NOV 23-25, 2024; Denver, USA.
[Poster]
FullText
Vlachos, G; Moser, T; Eberhard, A; Glaswitch, L; Blatterer, J; Bauernhofer, E; Monsberger, N; Kashofer, K; Geigl, JB; Bauernhofer, T; Heitzer, E
Non-invasive detection of homologous recombination deficiency in metastatic prostate cancer patients.
Annual Meeting. 2024; -AACR 2024; APR 5-10, 2024; San Diego, USA;.
[Poster]
FullText
Eberhard, A; Moser, T; Hammer, S; Glawitsch, L; Ziegler, L; Vlachos, G; Lang, K; Lazzeri, I; Bauernhofer, T; Balic, M; Loibner, M; Heitzer, E
Development of analysis workflows for urinary cell-free DNA in malignant disease
Advances in Circulating Tumor Cells - ACTC 2023; SEP 20-23, 2023; Skiathos, Greece. 2023.
[Poster]
FullText
Eberhard, A; Moser, T; Hammer, S; Lang, K; Faschauner, P; Vlachos, G; Belic, J; Lazzeri, I; Pichler, M; Speicher, M; Bauernhofer, T; Heitzer, E
Paired analysis of blood plasma and urine reveals complementary information
in prostate cancer
DocDay; FEB 9, 2023; Graz, AUSTRIA. 2023.
[Oral Communication]
Leithner, A; Seidel, MG; Moser, T; Thueringer, A; Liegl-Atzwanger, B; Szkandera, J; Benesch, M; El-Heliebi, A; Heitzer, E; Kashofer, K
Introducting liquid biopsy for paediatric patients into the clinical routine
Proceedings of the ESMO Sarcoma and Rare Cancers Congress 2023. 2023; -ESMO Sarcoma and Rare Cancers Congress; MAR 20-22, 2023; Lugano, SWITZERLAND.
[Poster]
Moser, T
Mammakarzinom: BRCA Testing Tumor-first?
Patho-Melange; NOV 11, 2023; Graz, AUSTRIA. 2023.
[Oral Communication]
Moser, T; Eberhard, A; Hammer, S; Glawitsch, L; Vlachos, G; Lazzeri, I; Lang, K; Faschauner, P; Belic, J; Pichler, M; Geigl, JB; Bauernhofer, T; Speicher, MR; Heitzer, E
Bridging urinary and plasma-based circulating tumor DNA analysis in prostate cancer.
Symposium of the Comprehensive Cancer Center. 2023; -CCC-Trio New Frontiers in Translational Oncology & Immuno-Oncology; APR 27-28, 2023; Vienna, AUSTRIA.
[Poster]
Moser, T; Eberhard, A; Hammer, S; Glawitsch, L; Vlachos, G; Lazzeri, I; Lang, K; Faschauner, P; Belic, J; Pichler, M; Geigl, JB; Bauernhofer, T; Speicher, MR; Heitzer, E.
It's a match – ctDNA in urine and plasma reveal complementary information in prostate cancer.
13th International Symposium on Minimal Residual Cancer. 2023; -ISMRC; MAY 2-4, 2023; Hamburg, GERMANY.
[Poster]
Moser, T; Moser; MJ; Heitzer, E
Cancer monitoring via blood.
Servier Seedpods Day; JUN 29, 2023; Paris-Saclay, FRANCE. 2023.
[Oral Communication]
Moser, T; Moser, MJ; Lockhart, Brian; Guigal-Stephan, Nolwen; Speicher, MR; Heitzer, E
It’s in our blood: Monitoring cancer treatment via circulating DNA fragmentomics.
Servier Seedpods Day; JUN 29, 2023; Paris-Saclay, FRANCE. 2023.
[Poster]
Seidel, M; Leithner, A; Kashofer, K; Moser, T; Thüringer, A; Liegl-Atzwanger, B; Szkandera, J; Benesch, M; El-Heliebi, A; Heitzer, E
Liquid Biopsy In Paediatric Ewing Sarcoma Patients: A Pilot Study.
Abstracts of the 24th EFORT Annual Congress:#2198. 2023; -24th EFORT Annual Congress; MAY 24-26, 2023; Vienna, AUSTRIA.
[Oral Communication]
Vlachos, G; Moser, T; Bauernhofer, T; Heitzer, E
Investigating Homologous Recombination Deficiency in mCRPC through ctDNA.
ISMRC 13th International Symposium on Minimal Residual Cancer Book of Abstracts. 2023; -ISMRC 13th International Symposium on Minimal Residual Cancer; MAY 2-4, 2023;; Hamburg, GERMANY.
[Poster]
Vlachos, G; Moser, T; Bauernhofer, T; Heitzer, E
ctDNA can infer Homologous Recombination Deficiency in mCRPC patients.
6th ACTC - Advances in Circulating Tumor Cells Book of Abstracts. 2023; -6th ACTC - Advances in Circulating Tumor Cells; SEP 20-23, 2023; Skiathos, GREECE.
[Poster]
Moser, T
The future of cancer care.
Servier Seedpods Day; MAY 31, 2022; Paris, FRANCE. 2022.
[Oral Communication]
Moser, T; Erharter, L; Eberhard, A; Guigal-Stephan, N; Lockhart, B; Geigl, JB; Speicher, MR; Heitzer, E
Evaluation of two kits for epigenetic workflows from liquid biopsies.
Servier Seedpods Day; MAY 31, 2022; Paris, FRANCE. 2022.
[Poster]
Moser, T; Hasenleithner, SO; Waldispuehl-Geigl, J; Zhou, Q; Weber, S; Graf, R; Geigl, JB; Heitzer, E; Speicher, MR
It’s in our blood: Improving cancer treatment monitoring via liquid biomarkers.
Festival of Genomics & Biodata; JAN 25-28, 2022; London, ENGLAND. 2022.
[Oral Communication]
Scheipl, S; Brcic, I; Moser, T; Fischerauer, S; Riedl, J; Bergovec, M; Smolle, M; Posch, F; Gerger, A; Pichler, M; Stöger, H; Leithner, A; Heitzer, E; Liegl, B; Szkandera, J
Die molekularpathologische Testung von Weichteilsarkomen mittels FoundationOne® Heme bestätigt potentielle therapeutische Targets: Ergebnisse einer monozentrischen Analyse
Abstractband 1. Österreichischer Kongress für Orthopädie & Traumatologie. 2022; -1. Österreichischer Kongress für Orthopädie & Traumatologie; 12.-14. Mai, 2022; Graz, Austria.
[Poster]
Seidel, M; Leithner, A; Kashofer, K; Moser, T; Thueringer, A; Liegl-Atzwanger, B; Szkandera, J; Benesch, M; El-Heliebi, A; Heitzer, E
Ewing sarcoma and liquid biopsy: plasma ctDNA quantification by ddPCR for monitoring residual disease
21st General Meeting of the International Society of Limb Salvage; IL5. 2022; 11-11.-21st General Meeting of the International Society of Limb Salvage; SEP 6-9, 2022; Los Angeles, USA.
[Oral Communication]
Seidel, MG; Leithner, A; Kashofer, K; Moser, T; Theuringer, A; Liegl-Atzwanger, B; Benesch, M; Szkandera, J; El-Heliebi, A; Heitzer, E
Liquid biopsy for monitoring paediatric Ewing sarcoma patients.
Abstract Book of the 34th Annual Meeting of the European Musculoskeletal Oncology Society (EMSOS). 2022; 27--34th Annual Meeting of the European Musculoskeletal Oncology Society (EMSOS); OCT 17-19, 2022; London, GREAT BRITAIN.
[Oral Communication]
Georgios Vlachos, Sabrina Weber, Tina Moser, Kevin Lang, Paul Faschauner, Anna Eberhard, Jelena Belic, Isaac Lazzeri, Martin Pichler, Michael Speicher, Thomas Bauernhofer, Ellen Heitzer
Paired analysis of blood plasma and urine reveals complementary information in prostate cancer
Advances in circulating tumor cells ; SEP 22-25, 2021; Kalamata, GREECE. 2021.
[Poster]
FullText
Kühberger, S; Weber, S; Graf, R; Moser, T; Spiegl, B, Hasenleithner, SO; Speicher, MR; Schuuring, E; Groen, HJM; Heitzer, E.
Genomewide copy number calling from enriched sequencing data to identify clinically relevant somatic copy number alterations
5th Advances in Circulating Tumor Cells: “Liquid Biopsy in its best” (ACTC 2021) ; SEP 22-25, 2021; Kalamata, GREECE. 2021.
[Poster]
Weber, S; van der Leest, P; Donker, HC; Schlange, T; Timens, W; Tamminga, M; Hasenleithner, SO; Graf, R; Moser, T; Spiegl, B; Yaspo, ML, Terstappen, LWMM; Sidorenkov, G; Hiltermann, TJN; Speicher, MR; Schuuring, E; Groen, HJM;Heitzer, E.
Dynamic changes of circulating tumor DNA predict clinical outcome in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors
5th Advances in Circulating Tumor Cells: “Liquid Biopsy in its best” (ACTC 2021) ; SEP 22-25, 2021; Kalamata, GREECE. 2021.
[Poster]
Hofmann, L; Sallinger, K; Haudum, C; Smolle, M; Heitzer, E; Moser, T; Novy, M; Gesson, K; Kroneis, T; Bauernhofer, T; El-Heliebi, A
Improved sensitivity of liquid biopsies in prostate cancer: A multi-analyte approach.
EACR Liquid Biopsies Virtual Event; NOV 18-19, 2020; Nottingham, UK. 2020.
[Poster]
Hofmann, L; Sallinger, K; Haudum, C; Smolle, M; Heitzer, E; Moser, T; Novy, M; Gesson, K; Kroneis, T; Bauernhofer, T; El-Heliebi, A
Another step towards personalized medicine: A multi-analyte approach for improved sensitivity of liquid biopsies in prostate cancer.
4th Annual Meeting of the ÖPPM; Vienna, AUSTRIA. 2020.
[Poster]
Moser, T; Waldispuehl-Geigl, J; Belic, J; Perakis, S; Weber, S; Zhou, Q; Sill, H; Lax, S; Kashofer, K; Hoefler, G; Schoellnast, H; Bauernhofer, T; Heitzer, E; Geigl, JB; Speicher, MR
Early circulating tumor DNA dynamics as a real-time predictor of FOLFOX efficacy in advanced colorectal cancer patients
CANCER RES. 2020; 80(16):
Doi: 10.1158/1538-7445.AM2020-4295
[Poster]
Web of Science
FullText
FullText_MUG
Moser, T; Waldispuehl-Geigl, J; Belic, J; Weber, S; Zhou, Q; Hasenleithner, S; Graf, R; Terzic, JA; Posch, F; Sill, H; Lax, S; Kashofer, K; Hoefler, G; Schoellnast, H; Bauernhofer, T; Heitzer, E; Geigl, JB; Speicher, MR
Real-time measurements of circulating tumor DNA levels during FOLFOX treatment in patients with colorectal cancer.
4th Annual Meeting of the ÖPPM; Vienna, AUSTRIA. 2020.
[Poster]
Lazzeri, I; Perakis, S; Moser, T; Zhou, Q; Ulz, P; Speicher, M; Heitzer, E
Building a cell type specific signature matrix for methylation based tissue deconvolution
DOCTORAL DAY 2019; NOV 20, 2019; Graz, Austria. 2019.
[Poster]
Moser, T; Perakis, S; Pichler, M; Seles, M; Wcislo, G; Speicher, MR; Heitzer, E
Molecular profiling of circulating tumor DNA in plasma of patients with renal cancer.
30th Annual Meeting of the German Society of Humangenetics ; MAR 6-8, 2019; Weimar, GERMANY. 2019.
[Poster]
Moser, T; Smith, CG; Mouliere, F; Chandrananda, D; Pichler, M; Seles, M; Wcislo, G; Rosenfeld, N; Speicher, MR; Stewart, GD; Heitzer, E
Untargeted profiling of cell-free tumour DNA in plasma and urine of patients with renal tumours.
Circulating Nucleic Acids in Plasma and Serum (CNAPS); SEP 23-25, 2019; Jerusalem, ISRAEL. 2019.
[Poster]
Moser, T; Smith, CG; Mouliere, F; Pichler, M; Seles, M; Wcislo, G; Rosenfeld, N; Speicher, MR; Stewart, GD; Heitzer, E
Non-invasive tumor profiling via circulating tumor DNA in patients with renal tumors.
Doctoral Day 2019; NOV 21, 2019; Graz, AUSTRIA. 2019.
[Poster]
FullText
Moser, T; Smith, CG; Seles, M; Pichler, M; Wcislo, G; Eldridge, M; Mouliere, F; Heider, K; Warren, A; Rosenfeld, N; D Stewart, GD; Heitzer, E
Comprehensive characterization of ctDNA in plasma and urine reveals renal cell carcinoma as a low ctDNA tumor type.
Advances in Circulating Tumor Cells (ACTC) 2019; SEP 2-6, 2019; Corfu, GREECE. 2019.
[Oral Communication]
FullText
Moser, T; Smith, CG; Seles, M; Wcislo, G; Eldridge, M; Perakis, S; Mouliere, F; Lazzeri, I; Heider, K; Warren, A; Rosenfeld, N; Stewart, GD; Heitzer, E
Comprehensive characterization of cell-free tumor DNA in plasma and urine of patients with renal tumors.
CANCER RES. 2019; 79(13):-AACR Annual Meeting on Bioinformatics, Convergence Science, and Systems Biology; MAR 29-APR 03, 2019; Atlanta, GA.
Doi: 10.1158/1538-7445.AM2019-1367
[Poster]
Web of Science
FullText
FullText_MUG
Moser, T; Smith, CG; Seles, M; Wcislo, G; Eldridge, M; Perakis, S; Mouliere, F; Lazzeri, I; Heider, K; Warren, A; Rosenfeld, N; Stewart GD; Heitzer, E
Comprehensive characterisation of cell-free tumour DNA in plasma and urine of patients with renal tumours.
Current Developments in Non-invasive Biomarkers for Assessment of Cancer 2. 2019; -AACR; MAR 29-APR 3, 2019; Atlanta, Georgia, USA.
[Poster]
Smith, CG; Moser, T; Riediger, AL; Eldridge, M; Mouliere, F; Mitchell, TJ; Warren, A; Heitzer, E; Rosenfeld, N; Stewart, GD
Application of sensitive sequencing methods for comprehensive characterisation of cell-free tumour DNA in plasma and urine of patients with renal tumours.
Circulating Nucleic Acids in Plasma and Serum (CNAPS); SEP 23-25, 2019; Jerusalem, ISRAEL. 2019.
[Poster]
Ulz, P; Perakis, S; Zhou, Q; Moser, T; Belic, J; Lazzeri, I; Wölfler, A; Zebisch, A; Gerger, A; Pristauz, G; Petru, E; White, B; Roberts, C; St. John, J; Schimek, MG; Geigl, JB; Bauernhofer, T; Sill, H; Bock, C; Heitzer, E; Speicher,M
Inference of tumor cell-specific transcription factor binding from cell-free DNA enables tumor subtype prediction
Circulating Nucleic Acids in Plasma and Serum (CNAPS); SEP 23-25, 2019; Jerusalem, Israel. 2019.
[Poster]
FullText
Lazzeri, I; Perakis, S; Moser, T; Zhou, Q; Ulz, P; Heitzer, E; Speicher, M
Patterns of aging in diverse liquid biopsy assays
Young Investigator Retreat; 1- 4, 2018; Seeboden, AUSTRIA. 2018.
[Oral Communication]
Moser, T; Ulz, P; Zhou, Q; Perakis, Samantha; Geigl, JB; Speicher, MR; Heitzer, E
Single-stranded library preparation does not preferentially enrich circulating tumor DNA.
11th International Symposium on Minimal Residual Cancer. 2018; -ISMRC; MAY 3-5, 2018; Montpellier, FRANCE.
[Poster]
Moser, T; Fertl, E; Koppi, S; Seifert-Held, T; Safoschnik, G; Bsteh, G; Heller, T; Rommer, P; Baumgartner, A; Berger, T; Sellner, J
Natalizumab-related progressive multifocal leukoencephalopathy in Austria: An observational nationwide study
EUR J NEUROL. 2017; 24: 38-38.-3rd Congress of the European-Academy-of-Neurology; JUN, 2017; Amsterdam, NETHERLANDS.
[Poster]
Web of Science
Moser, T; Ulz, P; Zhou, Q; Perakis, S; Geigl, JB; Speicher, MR; Heitzer, E
Single-stranded library preparation does not preferentially enrich circulating tumor DNA.
Doctoral Day 2017; DEC 13, 2017; Graz, AUSTRIA. 2017.
[Poster]
Ulz P, Perakis S, Zhuo Q, Moser T, Speicher MR and Heitzer E
Nucleosome positioning as cancer biomarker
https://doi.org/10.1177/1010428317742551 . 2017; -ISOBM; SEP 4-7, 2017; Rio de Janerio, BRASIL.
[Oral Communication]
FullText